Mullerian inhibiting substance inhibits growth of a human ovarian cancer in nude mice.

Por Donahoe, P K, Fuller, A F, Scully, R E, Guy, S R, Budzik, G P
Publicado em 1981

A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumours

Por Penson, R T, Seiden, M V, Matulonis, U A, Appleman, L J, Fuller, A F, Goodman, A, Campos, S M, Clark, J W, Roche, M, Eder, J P
Publicado em 2005

TEN-YEAR FOLLOW UP OF A PHASE II STUDY OF DOSE-INTENSE PACLITAXEL WITH CISPLATIN AND CYCLOPHOSPHAMIDE AS INITIAL THERAPY FOR POOR-PROGNOSIS ADVANCED-STAGE EPITHELIAL OVARIAN CANCER

Por Sarosy, Gisele A., Hussain, Mahrukh M., Seiden, Michael V., Fuller, A.F., Nikrui, N., Goodman, Annekathryn, Minasian, Lori, Reed, Eddie, Steinberg, Seth M., Kohn, Elise C.
Publicado em 2010